Ross Firestone is an Oncology physician. OpenAlex indexes 102 publications with 500 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
225 Summit Ave
Montvale, NJ 076451523
Telephone
201-775-7000Provider last certified this registry record 13 May 2025.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- PFIZER INC.Program year20251 payment
- Janssen Scientific Affairs, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.7%Statin27.4%Simvastatin56%Atorvastatin Calcium44%Part D<11 patientsCalcium channel blocker19.6%Amlodipine Besylate76%Nifedipine Er24%Part D<11 patients+ 2 more classes in this area
Nervous system
19.6%Other antidepressants7.8%Mirtazapine100%Part D<11 patientsAtypical Antipsychotic7%Risperidone100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
13%Biguanide (metformin)7%Metformin Hcl100%Part D<11 patientsH2 blocker6.1%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies
Clinical Lymphoma Myeloma & Leukemia
2026 - Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”